BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 30311721)

  • 1. Gut microbiome can be restored without adverse events after Helicobacter pylori eradication therapy in teenagers.
    Gotoda T; Takano C; Kusano C; Suzuki S; Ikehara H; Hayakawa S; Andoh A
    Helicobacter; 2018 Dec; 23(6):e12541. PubMed ID: 30311721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helicobacter pylori eradication with bismuth quadruple therapy leads to dysbiosis of gut microbiota with an increased relative abundance of Proteobacteria and decreased relative abundances of Bacteroidetes and Actinobacteria.
    Hsu PI; Pan CY; Kao JY; Tsay FW; Peng NJ; Kao SS; Wang HM; Tsai TJ; Wu DC; Chen CL; Tsai KW;
    Helicobacter; 2018 Aug; 23(4):e12498. PubMed ID: 29897654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helicobacter pylori Eradication Causes Perturbation of the Human Gut Microbiome in Young Adults.
    Yap TW; Gan HM; Lee YP; Leow AH; Azmi AN; Francois F; Perez-Perez GI; Loke MF; Goh KL; Vadivelu J
    PLoS One; 2016; 11(3):e0151893. PubMed ID: 26991500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota changes related to Helicobacter pylori eradication with vonoprazan containing triple therapy among adolescents: a prospective multicenter study.
    Kakiuchi T; Yamamoto K; Imamura I; Hashiguchi K; Kawakubo H; Yamaguchi D; Fujioka Y; Okuda M
    Sci Rep; 2021 Jan; 11(1):755. PubMed ID: 33436953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term changes in the gut microbiota after triple therapy, sequential therapy, bismuth quadruple therapy and concomitant therapy for Helicobacter pylori eradication in Chinese children.
    Zhou Y; Ye Z; Wang Y; Huang Z; Zheng C; Shi J; Tang W; Zhang P; Wang S; Huang Y
    Helicobacter; 2021 Aug; 26(4):e12809. PubMed ID: 33899288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The eradication of Helicobacter pylori restores rather than disturbs the gastrointestinal microbiota in asymptomatic young adults.
    He C; Peng C; Wang H; Ouyang Y; Zhu Z; Shu X; Zhu Y; Lu N
    Helicobacter; 2019 Aug; 24(4):e12590. PubMed ID: 31124220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H. pylori eradication with antibiotic treatment causes changes in glucose homeostasis related to modifications in the gut microbiota.
    Martín-Núñez GM; Cornejo-Pareja I; Coin-Aragüez L; Roca-Rodríguez MDM; Muñoz-Garach A; Clemente-Postigo M; Cardona F; Moreno-Indias I; Tinahones FJ
    PLoS One; 2019; 14(3):e0213548. PubMed ID: 30870471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered Gut Microbiota and Short-Chain Fatty Acids After Vonoprazan-Amoxicillin Dual Therapy for
    Hu Y; Xu X; Ouyang YB; He C; Li NS; Xie C; Peng C; Zhu ZH; Shu X; Xie Y; Lu NH; Zhu Y
    Front Cell Infect Microbiol; 2022; 12():881968. PubMed ID: 35719338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in the human gut microbiota composition caused by Helicobacter pylori eradication therapy: A systematic review and meta-analysis.
    Ye Q; Shao X; Shen R; Chen D; Shen J
    Helicobacter; 2020 Aug; 25(4):e12713. PubMed ID: 32515529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of Helicobacter pylori infection and eradication therapy containing minocycline and metronidazole on intestinal microbiota.
    Cui MY; Cui ZY; Zhao MQ; Zhang MJ; Jiang QL; Wang JJ; Lu LG; Lu YY
    BMC Microbiol; 2022 Dec; 22(1):321. PubMed ID: 36581836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of gut microbiome and metabolome in
    White B; Sterrett JD; Grigoryan Z; Lally L; Heinze JD; Alikhan H; Lowry CA; Perez LJ; DeSipio J; Phadtare S
    World J Gastroenterol; 2021 Sep; 27(33):5575-5594. PubMed ID: 34588753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of Probiotics on Gut Microbiota during the Helicobacter pylori Eradication: Randomized Controlled Trial.
    Oh B; Kim BS; Kim JW; Kim JS; Koh SJ; Kim BG; Lee KL; Chun J
    Helicobacter; 2016 Jun; 21(3):165-74. PubMed ID: 26395781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Gut Microbiota and
    Gao JJ; Zhang Y; Gerhard M; Mejias-Luque R; Zhang L; Vieth M; Ma JL; Bajbouj M; Suchanek S; Liu WD; Ulm K; Quante M; Li ZX; Zhou T; Schmid R; Classen M; Li WQ; You WC; Pan KF
    Front Cell Infect Microbiol; 2018; 8():202. PubMed ID: 29971220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic changes in antibiotic resistance genes and gut microbiota after Helicobacter pylori eradication therapies.
    Wang L; Yao H; Tong T; Lau K; Leung SY; Ho JWK; Leung WK
    Helicobacter; 2022 Apr; 27(2):e12871. PubMed ID: 34969161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term and long-term impacts of Helicobacter pylori eradication with reverse hybrid therapy on the gut microbiota.
    Hsu PI; Pan CY; Kao JY; Tsay FW; Peng NJ; Kao SS; Chen YH; Tsai TJ; Wu DC; Tsai KW
    J Gastroenterol Hepatol; 2019 Nov; 34(11):1968-1976. PubMed ID: 31115933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probiotics modulate gastrointestinal microbiota after
    He C; Xie Y; Zhu Y; Zhuang K; Huo L; Yu Y; Guo Q; Shu X; Xiong Z; Zhang Z; Lyu B; Lu N
    Front Immunol; 2022; 13():1033063. PubMed ID: 36426355
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Yang L; Zhang J; Xu J; Wei X; Yang J; Liu Y; Li H; Zhao C; Wang Y; Zhang L; Gai Z
    Front Cell Infect Microbiol; 2019; 9():375. PubMed ID: 31781514
    [No Abstract]   [Full Text] [Related]  

  • 18. The impact of Helicobacter pylori infection, eradication therapy and probiotic supplementation on gut microenvironment homeostasis: An open-label, randomized clinical trial.
    Chen L; Xu W; Lee A; He J; Huang B; Zheng W; Su T; Lai S; Long Y; Chu H; Chen Y; Wang L; Wang K; Si J; Chen S
    EBioMedicine; 2018 Sep; 35():87-96. PubMed ID: 30145102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal microbiome and
    Sitkin S; Lazebnik L; Avalueva E; Kononova S; Vakhitov T
    World J Gastroenterol; 2022 Feb; 28(7):766-774. PubMed ID: 35317277
    [No Abstract]   [Full Text] [Related]  

  • 20. Long term impact of vonoprazan-based Helicobacter pylori treatment on gut microbiota and its relation to post-treatment body weight changes.
    Suzuki S; Gotoda T; Takano C; Horii T; Sugita T; Ogura K; Ichijima R; Kusano C; Ikehara H
    Helicobacter; 2021 Dec; 26(6):e12851. PubMed ID: 34486195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.